Developer docs
API playgroundTry for free, no card

Search company profiles

Urgo laboratories

Full company profile

uuid000ayak

Namestring
Urgo laboratories
Legal namestring
Laboratoires Urgo Healthcare
Websiteurl
urgo.com
Company typeenum
Private
Founded yearint
1958
Descriptiontext

Urgo Laboratories (legal entity: Laboratoires Urgo Healthcare) is a privately held French consumer healthcare company founded in 1958 and headquartered in Chenôve, France. The company develops, manufactures, and sells over-the-counter wound care, first aid, dermatological, foot care, and pain management products under the URGO brand and a portfolio of proprietary technology platforms including Filmogel® (liquid film-forming plasters), Filmomousse® (foaming emulsion), Filmocrème® (lightweight emulsion), Hydrocolloïde, Lipido-colloïde, TENS, medical-grade honey, Syndet purifiant, and micro-needling delivery systems. Product categories span burns, blisters, cold sores, warts, nail fungus, acne, dry/cracked skin, muscle and joint pain, and women's health, with multiple recent launches including a full acne-prone skin line and a licensed Harry Potter-themed children's plaster range.

Urgo operates a direct-to-consumer go-to-market, distributing through its own e-commerce platform (urgo.fr) and through France-wide pharmacy and retail channels. Revenue is generated through one-time product sales of OTC medical devices and consumer health SKUs; no subscription, licensing, or enterprise B2B revenue streams are disclosed. The company employs between 1,001 and 5,000 people, operates exclusively in the French market, and is not publicly listed. No parent company, external investors, or funding rounds are disclosed in the available data, indicating a likely independent or family-owned ownership structure. Strategic activity in 2025-2026 has been concentrated in product expansion (acne skincare line, silicone bandage generation, foot care extension, Filmocrème platform) and one consumer-facing licensing partnership (Harry Potter plasters), with no M&A, geographic expansion, or restructuring events recorded.

Short descriptiontext

Urgo Laboratories is a French private consumer healthcare company founded in 1958 that develops and sells OTC wound care, first aid, dermatological, foot care, and pain management products under proprietary technologies such as Filmogel®, distributing via pharmacy retail and D2C e-commerce across France.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersChenôve, France
HQ citystring
Chenôve
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
wound care products, first aid supplies, dermatological treatments, film-forming bandages, OTC healthcare
Industry3 codes
PRIMARYCRADAMAB
First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIACAL
Dermatology Specialty Pharmaceuticals
SECONDARYCRADANAK
Foot Care (Deodorizing, Anti-chafe, Callus Care)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Consumer Fragrances & Personal Care Manufacturing (Non-cosmetic)
NAICS code3 codes
  • Medical Equipment and Supplies Manufacturing3391
  • Toilet Preparation Manufacturing325620
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Surgical & Medical Instruments & Apparatus3841
Product category
Consumer Healthcare & Wound Care Products
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Consumer Healthcare Products
TypeOne Time License
Description

Sale of over-the-counter healthcare and wound care products including bandages, treatments for burns, blisters, cold sores, acne, foot care, and muscle pain. Products are sold through e-commerce and retail/pharmacy channels.

urgo.fr
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Urgo Laboratories (Laboratoires Urgo Healthcare) manufactures and sells over-the-counter consumer healthcare products for wound care, first aid, and dermatological treatments. Its portfolio covers treatments for burns, blisters, warts, nail fungus, cold sores, acne-prone skin, dry/cracked skin, muscle pain, and insect bites, delivered through proprietary technologies such as Filmogel®, Filmomousse®, Filmocrème®, hydrocolloid, lipido-colloid, TENS, medical honey, and micro-needling systems. Products are distributed directly to consumers through the urgo.fr e-commerce site and through pharmacy/retail channels in France.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 4.5/5 rating based on 866 customer evaluations for URGO Filmogel Mycose product
+1 more record
Product overview1 text field

Urgo Laboratories (Laboratoires Urgo Healthcare) is a French healthcare company founded in 1958, specializing in wound care, first aid, and dermatological treatments. The product portfolio centers on proprietary technologies including Filmogel®, Filmomousse®, Filmocrème®, Hydrocolloïde, Lipido-colloïde, TENS, Miel médical, Syndet purifiant, and Micro-needling. The core product offerings span multiple categories: essential treatments for burns, warts, nail fungus and trauma, and foot care; first aid products for wound protection, dressing fixation, wound healing, oral care, insect bites, and antiseptics; pain management including muscle pain relief and joint/muscle support; and skin health products for dry/cracked skin, damaged skin, atopic skin, cold sores, and acne-prone skin. The recent expansion includes an acne-prone skin product line (Gamme Peau à tendance acnéique) featuring multiple delivery formats: URGO Filmogel® Boutons localisés, URGO Patch hydrocolloïde micro-needling, URGO Syndet Purifiant, and URGO Concentré Sébo-régulateur.

Product and service3 records
1URGO Filmogel® Boutons localisés
CategoryAcne treatment
Description

Filmogel® technology product for treating localized breakouts on acne-prone skin; forms a protective film over pimples for French consumer market.

2URGO Patch hydrocolloïde micro-needling
CategoryAcne treatment
Description

Hydrocolloid patch combined with micro-needling technology for treating acne-prone skin; creates micro-channels for enhanced active absorption.

3URGO Syndet Purifiant
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthers
Description

Google Inc. serves as a partner for web analytics (Google Analytics) and advertising services (Google Ads, Google AdWords Pixel) on the urgo.fr website, providing audience measurement and performance advertising capabilities. This is a vendor/technology partnership for digital marketing operations rather than a core business partnership.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Owner of Hansaplast/Elastoplast, the leading European adhesive bandage brand, and Eucerin in dermo-cosmetics. Directly competes with Urgo across wound care plasters and dermatology/skincare categories in France and broader Europe.

TypeDirect peer
Description

Bayer's Bepanthen/Bepanthol line covers wound healing creams, antiseptics, and sensitive-skin products — directly competing with Urgo in first aid and minor wound treatment categories across Europe.

TypeDirect peer
Description

French dermo-cosmetic brand within L'Oréal focused on sensitive, acne-prone, and atopic skincare. Directly comparable to Urgo's acne range (Filmocrème, Syndet Purifiant, sébo-régulateur) and broader dermatology franchise.

TypeBroad incumbent
Description

Global wound care company with hydrocolloid and advanced dressing lines. Technology overlap with Urgo's hydrocolloïde platform and wound care franchise.

TypeBroad incumbent
Description

Diversified medical and consumer health business with significant wound care and skin-treatment product lines. Adjacent competitor to Urgo in advanced wound care technology and OTC-format products.

TypeBroad incumbent
Description

Danish specialist in wound and skin care (including hydrocolloid-based dressings). Comparable technology overlap with Urgo's hydrocolloïde platform, though Coloplast is more focused on chronic/stoma care.

TypeDirect peer
Description

German specialist in wound management (hydrocolloid, foam, and advanced dressings) with a wide pharmacy channel. Comparable to Urgo on professional wound care technologies (Lipido-colloïde, Hydrocolloïde).

Description

French pharmaceutical and dermo-cosmetic group with dermatology brands (Avène, Ducray, A-Derma) plus OTC ranges. Closest French-headquartered peer to Urgo, competing across dermatology, foot care, and OTC channels in pharmacies.

9Johnson & Johnson (Band-Aid / Neutrogena)
TypeBroad incumbent
Description

Band-Aid is the global category leader in adhesive bandages and J&J's Neutrogena covers acne-prone skincare. Overlaps directly with Urgo's wound care and acne-line extensions, though J&J operates as a much larger diversified healthcare incumbent.

TypeOthers
Description

Separately branded Urgo entity serving healthcare professionals in advanced wound care. Adjacent ecosystem participant sharing the Urgo brand, technology platforms, and parent group, though serving a different channel (clinicians/hospitals vs. consumer).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Urgo laboratories

Consumer Healthcare & Wound Care Productsurgo.com

Urgo Laboratories is a French private consumer healthcare company founded in 1958 that develops and sells OTC wound care, first aid, dermatological, foot care, and pain management products under proprietary technologies such as Filmogel®, distributing via pharmacy retail and D2C e-commerce across France.

What Urgo laboratories does

Urgo Laboratories (legal entity: Laboratoires Urgo Healthcare) is a privately held French consumer healthcare company founded in 1958 and headquartered in Chenôve, France. The company develops, manufactures, and sells over-the-counter wound care, first aid, dermatological, foot care, and pain management products under the URGO brand and a portfolio of proprietary technology platforms including Filmogel® (liquid film-forming plasters), Filmomousse® (foaming emulsion), Filmocrème® (lightweight emulsion), Hydrocolloïde, Lipido-colloïde, TENS, medical-grade honey, Syndet purifiant, and micro-needling delivery systems. Product categories span burns, blisters, cold sores, warts, nail fungus, acne, dry/cracked skin, muscle and joint pain, and women's health, with multiple recent launches including a full acne-prone skin line and a licensed Harry Potter-themed children's plaster range.

Urgo operates a direct-to-consumer go-to-market, distributing through its own e-commerce platform (urgo.fr) and through France-wide pharmacy and retail channels. Revenue is generated through one-time product sales of OTC medical devices and consumer health SKUs; no subscription, licensing, or enterprise B2B revenue streams are disclosed. The company employs between 1,001 and 5,000 people, operates exclusively in the French market, and is not publicly listed. No parent company, external investors, or funding rounds are disclosed in the available data, indicating a likely independent or family-owned ownership structure. Strategic activity in 2025-2026 has been concentrated in product expansion (acne skincare line, silicone bandage generation, foot care extension, Filmocrème platform) and one consumer-facing licensing partnership (Harry Potter plasters), with no M&A, geographic expansion, or restructuring events recorded.

Urgo laboratories firmographics

Firmographics
Name
Urgo laboratories
Legal name
Laboratoires Urgo Healthcare
Website
https://urgo.com
Company type
Private
Founded year
1958
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Urgo Laboratories is a French private consumer healthcare company founded in 1958 that develops and sells OTC wound care, first aid, dermatological, foot care, and pain management products under proprietary technologies such as Filmogel®, distributing via pharmacy retail and D2C e-commerce across France.
Ownership category
akta.pro rank

Urgo laboratories industry classification

Industry
Product category
Consumer Healthcare & Wound Care Products
NAICS
Medical Equipment and Supplies Manufacturing (3391), Toilet Preparation Manufacturing (325620), Pharmaceutical Preparation Manufacturing (325412)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYCRADAMAB
First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIACAL
Dermatology Specialty Pharmaceuticals
SECONDARYCRADANAK
Foot Care (Deodorizing, Anti-chafe, Callus Care)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Consumer Fragrances & Personal Care Manufacturing (Non-cosmetic)

Keywords

  • Wound care products
  • First aid supplies
  • Dermatological treatments
  • Film-forming bandages
  • OTC healthcare

Where Urgo laboratories is headquartered

Location

Headquarters

HQ city
Chenôve
HQ country
France
HQ region
Europe

Markets served

Urgo laboratories business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Consumer Healthcare Products: Sale of over-the-counter healthcare and wound care products including bandages, treatments for burns, blisters, cold sores, acne, foot care, and muscle pain. Products are sold through e-commerce and retail/pharmacy channels.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Urgo laboratories product offering

Product offering

Core offering

Urgo Laboratories (Laboratoires Urgo Healthcare) manufactures and sells over-the-counter consumer healthcare products for wound care, first aid, and dermatological treatments. Its portfolio covers treatments for burns, blisters, warts, nail fungus, cold sores, acne-prone skin, dry/cracked skin, muscle pain, and insect bites, delivered through proprietary technologies such as Filmogel®, Filmomousse®, Filmocrème®, hydrocolloid, lipido-colloid, TENS, medical honey, and micro-needling systems. Products are distributed directly to consumers through the urgo.fr e-commerce site and through pharmacy/retail channels in France.

Product overview

Urgo Laboratories (Laboratoires Urgo Healthcare) is a French healthcare company founded in 1958, specializing in wound care, first aid, and dermatological treatments. The product portfolio centers on proprietary technologies including Filmogel®, Filmomousse®, Filmocrème®, Hydrocolloïde, Lipido-colloïde, TENS, Miel médical, Syndet purifiant, and Micro-needling. The core product offerings span multiple categories: essential treatments for burns, warts, nail fungus and trauma, and foot care; first aid products for wound protection, dressing fixation, wound healing, oral care, insect bites, and antiseptics; pain management including muscle pain relief and joint/muscle support; and skin health products for dry/cracked skin, damaged skin, atopic skin, cold sores, and acne-prone skin. The recent expansion includes an acne-prone skin product line (Gamme Peau à tendance acnéique) featuring multiple delivery formats: URGO Filmogel® Boutons localisés, URGO Patch hydrocolloïde micro-needling, URGO Syndet Purifiant, and URGO Concentré Sébo-régulateur.

Differentiator

Problem solved

Functional benefit

Products and services

  • URGO Filmogel® Boutons localisés Filmogel® technology product for treating localized breakouts on acne-prone skin; forms a protective film over pimples for French consumer market.
  • URGO Patch hydrocolloïde micro-needling Hydrocolloid patch combined with micro-needling technology for treating acne-prone skin; creates micro-channels for enhanced active absorption.
  • URGO Syndet Purifiant

Quantifiable outcome

  • 4.5/5 rating based on 866 customer evaluations for URGO Filmogel Mycose product
  • +1 more outcomes

Companies that use Urgo laboratories

Customer profile

Segments1 record

Ideal customer profiles1 record

Urgo laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

Urgo laboratories partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Google Inc.minorOthersGoogle Inc. serves as a partner for web analytics (Google Analytics) and advertising services (Google Ads, Google AdWords Pixel) on the urgo.fr website, providing audience measurement and performance advertising capabilities. This is a vendor/technology partnership for digital marketing operations rather than a core business partnership.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Urgo laboratories competitors and assessment

Company assessment

Direct peers

  • Beiersdorf: Owner of Hansaplast/Elastoplast, the leading European adhesive bandage brand, and Eucerin in dermo-cosmetics. Directly competes with Urgo across wound care plasters and dermatology/skincare categories in France and broader Europe.
  • Bayer Consumer Health (Bepanthen): Bayer's Bepanthen/Bepanthol line covers wound healing creams, antiseptics, and sensitive-skin products — directly competing with Urgo in first aid and minor wound treatment categories across Europe.
  • La Roche-Posay (L'Oréal): French dermo-cosmetic brand within L'Oréal focused on sensitive, acne-prone, and atopic skincare. Directly comparable to Urgo's acne range (Filmocrème, Syndet Purifiant, sébo-régulateur) and broader dermatology franchise.
  • Hartmann Group: German specialist in wound management (hydrocolloid, foam, and advanced dressings) with a wide pharmacy channel. Comparable to Urgo on professional wound care technologies (Lipido-colloïde, Hydrocolloïde).

Broad incumbents

  • ConvaTec: Global wound care company with hydrocolloid and advanced dressing lines. Technology overlap with Urgo's hydrocolloïde platform and wound care franchise.
  • 3M Health Care: Diversified medical and consumer health business with significant wound care and skin-treatment product lines. Adjacent competitor to Urgo in advanced wound care technology and OTC-format products.
  • Coloplast: Danish specialist in wound and skin care (including hydrocolloid-based dressings). Comparable technology overlap with Urgo's hydrocolloïde platform, though Coloplast is more focused on chronic/stoma care.
  • Johnson & Johnson (Band-Aid / Neutrogena): Band-Aid is the global category leader in adhesive bandages and J&J's Neutrogena covers acne-prone skincare. Overlaps directly with Urgo's wound care and acne-line extensions, though J&J operates as a much larger diversified healthcare incumbent.

Peers

  • Pierre Fabre: French pharmaceutical and dermo-cosmetic group with dermatology brands (Avène, Ducray, A-Derma) plus OTC ranges. Closest French-headquartered peer to Urgo, competing across dermatology, foot care, and OTC channels in pharmacies.

Others

  • Urgo Medical / SantéDom (related entity): Separately branded Urgo entity serving healthcare professionals in advanced wound care. Adjacent ecosystem participant sharing the Urgo brand, technology platforms, and parent group, though serving a different channel (clinicians/hospitals vs. consumer).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Urgo laboratories social profiles

Digital presence

Urgo laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Urgo laboratories leadership team

Management profile

Number of profiles

Urgo laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Urgo laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Urgo laboratories

What does Urgo laboratories do?

Urgo Laboratories (Laboratoires Urgo Healthcare) manufactures and sells over-the-counter consumer healthcare products for wound care, first aid, and dermatological treatments. Its portfolio covers treatments for burns, blisters, warts, nail fungus, cold sores, acne-prone skin, dry/cracked skin, muscle pain, and insect bites, delivered through proprietary technologies such as Filmogel®, Filmomousse®, Filmocrème®, hydrocolloid, lipido-colloid, TENS, medical honey, and micro-needling systems. Products are distributed directly to consumers through the urgo.fr e-commerce site and through pharmacy/retail channels in France.

Is Urgo laboratories a public or private company?

Urgo laboratories is a private company. It is classified as unknown and is currently operating.

When was Urgo laboratories founded?

Urgo laboratories was founded in 1958. It employs 1,001 to 5,000 people.

Where is Urgo laboratories based?

Urgo laboratories is headquartered in Chenôve, France, in the Europe region.

How does Urgo laboratories make money?

One revenue line is on record: consumer Healthcare Products.

Who are Urgo laboratories's main competitors?

Direct peers on record are Beiersdorf, Bayer Consumer Health (Bepanthen), La Roche-Posay (L'Oréal) and Hartmann Group. Broad incumbents are ConvaTec, 3M Health Care, Coloplast and Johnson & Johnson (Band-Aid / Neutrogena). Pierre Fabre is listed as a peer. Urgo Medical / SantéDom (related entity) is listed as an others.

Does Urgo laboratories have an API?

No public API is recorded for Urgo laboratories.

What industry is Urgo laboratories in?

Urgo laboratories's product category is Consumer Healthcare & Wound Care Products. Its primary akta.pro industry code is CRADAMAB, First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care), with a secondary code of HLAIACAL, Dermatology Specialty Pharmaceuticals. Its NAICS code is 3391 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales